ESC 365 - Antithrombotic therapy post-PCI: applying evidence from RE-DUAL PCI to challenging cases.

Open Access

Antithrombotic therapy post-PCI: applying evidence from RE-DUAL PCI to challenging cases.

Session: NOACs in patients with atrial fibrillation: insights from the cardiac cath lab

Topic: Percutaneous Coronary Intervention (PCI)

Speaker: Professor J. ten Berg (Nieuwegein, NL)

Sponsored by Boehringer Ingelheim

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Professor Jurrien M ten Berg

St Antonius Hospital, Nieuwegein (Netherlands (The))

20 presentations

4 followers

4 more presentations in this session

Setting the scene: safety, efficacy, and reversal.

Speaker: Doctor J. Eikelboom (Hamilton, CA)

Finding order in complexity: dual versus triple antithrombotic therapy post-PCI.

Speaker: Professor D. Angiolillo (Jacksonville, US)

Practical tips on uninterrupted NOACs in atrial fibrillation ablation.

Speaker: Professor D. Gupta (Liverpool, GB) Professor J. Eikelboom (Hamilton, CA)

Panel discussion and audience questions: NOACs in cardiology settings.

Speaker: Professor J. Eikelboom (Hamilton, CA) Doctor D. Angiolillo (Jacksonville, US)

Access the full session

NOACs in patients with atrial fibrillation: insights from the cardiac cath lab

Speakers: Professor J. ten Berg, Doctor J. Eikelboom, Professor D. Angiolillo, Professor D. Gupta, Professor J. Eikelboom...

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources